Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer

Technology appraisal guidance
Reference number: TA422
Published: 21 December 2016

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 223 KB)

Published:

23 January 2017

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 353 KB)

Published:

10 November 2016
Committee papers (PDF 1.37 MB)

Published:

10 November 2016

Invitation to participate

Final scope (PDF 47 KB)

Published:

18 July 2016
Final matrix (PDF 97 KB)

Published:

18 July 2016